Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2(+/-) mice: two-stage oxidative injury.
about
Mechanisms of drug-induced liver injuryDrug-induced liver injury: recent advances in diagnosis and risk assessment.Mitochondrial proteomics in experimental autoimmune uveitis oxidative stressMechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver.Upregulation of the mitochondrial Lon Protease allows adaptation to acute oxidative stress but dysregulation is associated with chronic stress, disease, and aging.The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity.Pleiotropic effects of glitazones: a double edge sword?Proteomics signature profiling (PSP): a novel contextualization approach for cancer proteomics.Integrative toxicoproteomics implicates impaired mitochondrial glutathione import as an off-target effect of troglitazoneDrug-induced liver injury: what was new in 2008?Mechanism-based bioanalysis and biomarkers for hepatic chemical stress.Mechanisms of drug toxicity and relevance to pharmaceutical development.Animal models of idiosyncratic drug-induced liver injury--current status.Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development.Mitochondria in metabolic disease: getting clues from proteomic studies.Current challenges and controversies in drug-induced liver injury.Deletion of GSTA4-4 results in increased mitochondrial post-translational modification of proteins by reactive aldehydes following chronic ethanol consumption in mice.
P2860
Q26998806-66130301-A528-40BC-9DF6-799F01F876C2Q30235089-37E0AC5C-B085-49F5-AE76-9AABF709A1BAQ33478305-9EA42C8B-04B7-41FE-A7DB-0328F6868F27Q33954265-7C3031BB-CFC9-462F-80EB-5277123771F8Q34235817-A4A79016-A40B-40B7-96C8-D02E303FB799Q34370238-A74B9179-B2AB-44C7-9348-06DAD290EE9EQ34630779-3DF5EF38-ED31-439D-A4C4-FB8B91F91AABQ35025858-6CCB0260-0722-4592-A033-FCCB3547D38DQ36320993-E7F81E76-00E0-4E5E-8582-B17C65B326B9Q37247744-675C7626-B5D7-4A83-9B74-DF7FBC24AB2FQ37510856-584C745F-DA1B-4B31-840A-7B078AD60005Q37557613-4EE86488-4358-47BE-9E0E-440D36790CE4Q37803316-310A54C8-971A-4901-9832-2A919F62509FQ37897219-54F68C70-9B19-4289-9557-0DD536B927BDQ37975546-9B7D1871-7942-4721-9A2B-9A404AFEDFB8Q38171425-A220873A-7BDA-4B24-9C42-CD2863BDF245Q39523252-C3F3B476-1AF8-4E18-AACB-64E42B340F00Q40224919-6F70E2FF-3D50-41BB-B36F-B34D5F3F0907
P2860
Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2(+/-) mice: two-stage oxidative injury.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Troglitazone-induced hepatic m ...... dynamics in heterozygous Sod2
@nl
Troglitazone-induced hepatic m ...... e: two-stage oxidative injury.
@ast
Troglitazone-induced hepatic m ...... e: two-stage oxidative injury.
@en
type
label
Troglitazone-induced hepatic m ...... dynamics in heterozygous Sod2
@nl
Troglitazone-induced hepatic m ...... e: two-stage oxidative injury.
@ast
Troglitazone-induced hepatic m ...... e: two-stage oxidative injury.
@en
prefLabel
Troglitazone-induced hepatic m ...... dynamics in heterozygous Sod2
@nl
Troglitazone-induced hepatic m ...... e: two-stage oxidative injury.
@ast
Troglitazone-induced hepatic m ...... e: two-stage oxidative injury.
@en
P2093
P1476
Troglitazone-induced hepatic m ...... e: two-stage oxidative injury.
@en
P2093
Maxey C M Chung
Qingsong Lin
Urs A Boelsterli
Yie Hou Lee
P356
10.1016/J.TAAP.2008.03.025
P577
2008-04-12T00:00:00Z